Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LXU Healthcare is a specialized medical technology company focused on the design, development, and manufacture of high-performance interventional medical devices. Headquartered in Shanghai, China, the company primarily serves the vascular intervention market, offering a range of products for coronary and peripheral artery procedures. Its core portfolio includes various balloon dilatation catheters, such as PTA, PTCA, and high-pressure balloons, many of which have secured both NMPA approval and CE marking. LXU Healthcare leverages advanced manufacturing techniques and material science to provide clinicians with precise tools for treating complex vascular conditions. The company is actively expanding its pipeline into drug-coated technologies and next-generation vascular access systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LXU Healthcare.